Prostatic Neoplasms, Castration-Resistant: Clinical Trials

4 trials for Prostatic Neoplasms, Castration-Resistant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 23Completed 3

Follow Prostatic Neoplasms, Castration-Resistant: new trials by email Literature Review of Prostatic Neoplasms, Castration-Resistant trials Research Report on Prostatic Neoplasms, Castration-Resistant

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
Ga-68 PSMA-HBED-CC PET - Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant
Phase 2 / Phase 3CompletedMichael Graham PhD, MD62019-03-012025-04-17
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm
Phase 2 / Phase 3CompletedMichael Graham PhD, MD302018-02-162024-07-12
68Ga PSMA in Preprostatectomy Patients
Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm
Phase 2 / Phase 3CompletedMichael Graham PhD, MD222018-02-162024-02-15
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
Atezolizumab, Enzalutamide - Prostatic Neoplasms, Castration-Resistant
Phase 3CompletedHoffmann-La Roche7592017-01-102024-08-09

Narrower conditions

Prostatic Neoplasms (3)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Genital Neoplasms, Male (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Prostatic Diseases (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Prostatic Neoplasms (1)

Interventions

atezolizumab (1)  ·  enzalutamide (1)

Sponsors

Michael Graham PhD, MD (3)  ·  Hoffmann-La Roche (1)

Countries

United States (4)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)

Top investigators

Michael Graham, MD, PhD (1)  ·  Michael M Graham, Ph.D., MD (1)  ·  Michael M. Graham, MD, PhD (1)

Results publications

PMID 35013615

NIH funding

2016 (1)